Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A
Public ClinicalTrials.gov record NCT00157040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Recombinant Antihemophilic Factor (rAHF-PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Pharmacokinetics, Immunogenicity, Efficacy and Safety in Previously Treated Pediatric Patients With Hemophilia A
Study identification
- NCT ID
- NCT00157040
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Baxalta now part of Shire
- Industry
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- Antihemophilic factor, recombinant, manufactured protein-free Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 6 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 6, 2002
- Primary completion
- Jan 3, 2005
- Completion
- Jan 3, 2005
- Last update posted
- Apr 26, 2021
2002 – 2005
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children´s Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Emory University, Department of Pediatrics | Atlanta | Georgia | 30322 | — |
| Children´s Memorial Hospital | Chicago | Illinois | 60614 | — |
| Comprehensive Bleeding Disorders Center | Peoria | Illinois | 61614 | — |
| Indiana Hemophilia and Thrombosis Center | Indianapolis | Indiana | 46260 | — |
| University of Iowa Hospitals and Clinics, Iowa Regional Hemophilia Center, Department of Pediatrics | Iowa City | Iowa | 52242 | — |
| University of Michigan Hemophilia Treatment Center | Ann Arbor | Michigan | 48109 | — |
| Children´s Hospital of Michigan | Detroit | Michigan | 48201 | — |
| Children´s Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| University of Texas Health Science Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00157040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00157040 live on ClinicalTrials.gov.